ArticleScientific reports2026
The involvement of miRNAs in CYP450 enzymes and UDP-glucuronosyltransferases regulation in the human liver.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
MicroRNAs play a key role in post-transcriptional regulation of genes. There is substantial evidence that miRNA regulate the transcription of genes involved in drug metabolism and transport. As the liver is the main organ contributing to the biotransformation of exogenous compounds including drugs, this study aimed to identify miRNAs that regulate the function of genes encoding enzymes crucial for drug biotransformation in the human liver. The identification of miRNAs potentially regulating pivotal cytochrome P450 enzymes and UDP-glucuronosyltransferase genes was performed via three different widely available web tools. Among the 479 predicted microRNA-target gene interactions, 22 unique miRNAs were detected at the quantitative level determined using qPCR low density arrays. The expression levels of these selected miRNAs were correlated with the target enzyme protein abundance quantified via mass spectrometry-based targeted proteomics. Significant negative correlations between miRNA expression and enzyme protein abundance were observed for CYP2C8, CYP2C9, CYP3A4, UGT1A1, UGT1A3 and UGT2B15. To verify the microRNA expression results, additional miRNA expression analysis (qPCR) in higher reaction volumes was performed. This analysis confirmed the statistically significant negative correlations between CYP2C8-hsa-miR-655-3p and UGT1A3-hsa-miR-200a-3p, and to validate the predicted interactions, in vitro experiments were conducted for these two miRNA-target pairs. For this purpose, HepG2 cells were co-transfected with pre-miR miRNA precursors (hsa-miR-655-3p and hsa-miR-200a-3p) and the respective enzyme 3'UTR constructs. A significant reduction in reporter activity confirmed the direct targeting of UGT1A3 by miR-200a-3p, while miR-655-3p had no significant effect on CYP2C8. These results provide insights into the miRNA-mediated epigenetic regulation of drug-metabolizing enzymes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.